📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy. (2014)

First Author: Lines JL

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2326-6066.cir-14-0072

PubMed Identifier: 24894088

Publication URI: http://europepmc.org/abstract/MED/24894088

Type: Journal Article/Review

Volume: 2

Parent Publication: Cancer immunology research

Issue: 6

ISSN: 2326-6066